Clinical Trials Browser

Observational × Neoplasm, Residual × Genitourinary × Clear all

NCT07112612 2026-01-12

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Not yet recruiting

Prostatic Neoplasms, Neoplasm, Residual

NCT02714790 2016-03-23

LAM-MMR

GenitourinaryOther hematologic neoplasm

Wilms Tumor, Leukemia, Myeloid, Acute, Neoplasm, Residual